
Myriad Genetics Announces Multiple Presentations at the 2019 American College of Rheumatology Annual Meeting
SALT LAKE CITY, Nov. 01, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and precision medicine, today announced that three studies on Vectra® will be featured at the 2019 American College of Rheumatology ( …